Dr. Robert Fremeau
Founder and CEO
Experienced R&D; leader with 20+ years of experience in academia and industry.
Dr. Blake Anson
Business development professional with deep commercial experience
Highlights
- 19+ years building new markets and driving paradigm-shifting tools into biopharma, government, and academic organizations.
- Senior Director, Discovery Research Partnering at FUJIFILM Cellular Dynamics.
- Former Vice President, Scientific Affairs, Partnering, and Business Development at Vyant Bio, StemoniX.
- Ph.D. in Neuroscience from the University of Oregon.
Biography
An internationally recognized business development professional with 19+ years of experience in building new markets and driving paradigm-shifting tools into pharmaceutical, academic, and government organizations. Deep commercial and scientific experience that together have enabled successful product development with cross-functional teams, directed and executed effective marketing initiatives, built strategic partnerships and identified and executed key business development opportunities. Blake earned his Ph.D. in neuroscience from the University of Oregon, where he investigated cardiac ion channels’ molecular and functional properties.
Colleagues
Dr. Maya Gosztyla
Co-founder and CSO
Neurobiologist with 5+ years of experience in cortical organoid disease models and applications of bioinformatics/machine learning in drug discovery.
Dr. Alysson Muotri
Stem cell and brain organoid pioneer
Created the first human organoid models for neurodevelopmental disorders.
Dr. James Treanor
Experienced biotech C-suite officer
Current BOD, SAB member, and former CEO at ADRx, Inc.
Dr. Mark H. Norman
Innovative medicinal chemist
30+ years of drug discovery and development experience.
Dr. Edoardo Marcora
Computational biology, software development, and genetics expertise
Professor of Genetics, Genomic Sciences, and Neuroscience, Mount Sinai Icahn School of Medicine; member of the Icahn Genomics Institute.
Get in touch
Talk to us about our precision neuroscience platform, our Parkinson’s disease program, or working with the BrainStorm team.